2′,3′-dideoxy-β-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 448-453

  Zoulim, Fabien ^a   Dannaoui, Eric ^a   Borel, Christelle ^a   Hantz, Olivier ^a   Lin, Tai Shun ^b   Liu, Shuey Huey ^b   Trépo, Christian ^a   Cheng, Yung Chi ^b  

^a INSERM   (France)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXY 5 FLUOROCYTIDINE; 2',3' DIDEOXYCYTIDINE DERIVATIVE; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; EMTRICITABINE; LAMIVUDINE; VIRUS DNA; ZALCITABINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DOSE RESPONSE; DRUG MECHANISM; HEPATITIS B; HEPATITIS B VIRUS; LIVER CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIREMIA; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; ANTIVIRAL AGENTS; BLOTTING, SOUTHERN; CELLS, CULTURED; DNA REPLICATION; DNA, VIRAL; DUCKS; FEMALE; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B VIRUS, DUCK; LIVER; REVERSE TRANSCRIPTASE INHIBITORS; TIME FACTORS; VIRUS REPLICATION; ZALCITABINE;

EID: 0030032079     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.448     Document Type: Article

References (32)

1. Chang, C.-N., S.-L. Doong, J. H. Zhou, J. W. Beach, L. S. Jeong, C. K. Chu, C.-H. Tsai, and Y.-C. Cheng. 1992. Deoxycytidine deaminase-resistant stereoisomer is the active form of (±) 2′,3′ dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication. J. Biol. Chem. 267:13938-13942.
2. Chen, C., and Y. Cheng. 1989 Delayed cytoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine J Biol. Chem. 264:11934-11937.
3. Cheng, Y.-C., et al. Unpublished data.
4. Condreay, L., R. Jansen, T. Powdrill, L. Johnson, D. Selleseth, M. Paff, S. Daluge, G. Painter, P. Furman, M. Ellis, and D. Averett. 1994. Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob. Agents Chemother. 38:616-619.
5. Doong, S.-L., C.-H. Tsai, R. F. Schinazi, D. C. Liotta, and Y.-C. Cheng. 1991. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc. Natl. Acad. Sci. USA 88:8495-8499.
6. Fourel, I., J. Cullen, J. Saputelli, C. Aldrich, P. Schaffer, D. Averett, J. Pugh, and W. Mason. 1994. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J. Virol. 68:8321-8330.
7. Fourel, I., P. Gripon, O. Hantz, L. Cova, V. Lambert, C. Jacquet, K. Watanabe, J. Fox, C. Guillouzo, and C. Trépo. 1989. Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: a useful system for antiviral testing. Hepatology 10:186-191.
8. Fourel, I., J. S. Li, O. Hantz, C. Jacquet, J. J. Fox, and C. Trépo. 1992 Effects of 2′-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and in liver of chronically infected ducks. J. Med. Virol. 37:122-126.
9. Fourel, I., J. Saputelli, P. Schaffer, and W. Mason. 1994. The carbocyclic analog of 2′-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver J. Virol. 68:1059-1065.
10. Goff, S., P. Traktman, and D. Baltimore. 1981. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase J. Virol. 38:239-248
11. Kassianides, C., J. H. Hoofnagle, R. H. Miller, E. Doo, S. Ford, S. Broder, and H. Mitsuya. 1989. Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxycytidine. Gastroenterology 97:1275-1280.
12. Lambert, V., S. Chassot, A. Kay, C. Trépo, and L. Cova. 1991. In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein. Virology 185:446-450
13. Lee, B., W. Luo, W. Suzuki, M. J. Robins, and D. L. J. Tyrell. 1989 In vitro and in vivo comparison of the abilities of purine and pyrimidine 2′,3′-dideoxynucleosides to inhibit duck hepadnavirus Antimicrob Agents Chemother. 33:336-339
14. Lin, T., M. Luo, M. Liu, S. Pai, G. Dutschman, and Y. Cheng. 1994 Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-F-ddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro. Biochem Pharmacol. 47:171-174.
15. Lin, T.-S., M.-Z. Luo, M.-C. Liu, S. B. Pai, G. E. Dutschman, and Y.-C. Cheng. 1994. Synthesis and biological evaluation of 2′,3′ dideoxy L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). J. Med. Chem. 37:798-803.
16. Marcellin, P., D. Ouzan, F. Degos, C. Bréchot, E. Metman, C. Degott, M. Chevallier, P. Berthelot, C. Trépo, and J. Benhamou. 1989. Randomized controlled trial of adenine arabinoside 5′-monophosphate in chronic active hepatitis B, comparison of the efficacy in heterosexual and homosexual patients Hepatology 10:328-331.
17. Mason, W., J. Cullen, J. Saputelli, T. Wu, C. Liu, W. London, E. Lustbader, P. Schaffer, A. O'Connell, I. Fourel, C. Aldrich, and A. Jilbert. 1994. Characterization of the antiviral activity of 2′carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology 19:398-411
18. Mason, W. S., and J. M. Taylor. 1989. Experimental systems for the study of hepadnavirus and hepatitis delta virus infections. Hepatology 9:635-645.
19. Perillo, R., E. Schiff, G. Davis, H. C. Bodenheimer, K. Lindsay, J. Payne, J. L. Dienstag, C. O'Brien, C. Tamburro, I. M. Jacobson, R. Sampliner, D. Feit, J. Lefkowitch, M. Kuhns, C. Meschievitz, B. Sanghvi, J. Albrecht, and A. Gibas. 1990. A randomized, controlled trial of interteron alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B N Engl. J. Med 323:295-301.
20. Popper, H., D. A. Shafritz, and J. H. Hoofnagle. 1987 Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 7:764-772
21. Seeger, C., and W. Mason. 1993 Hepadnavirus replication and approaches to antiviral therapy, p. 77-93 In W. Doerfler and P. Bohm (ed.), Virus strategies, vol. 4. VCH, Weinheim, Germany.
22. Sommadossi, J. 1994. Treatment of hepatitis B by nucleoside analogs: still a reality. Curr. Opin. Infect. Dis. 7:678-682.
23. Summers, J., P. M. Smith, and A. L. Horwich. 1990. Hepadnaviral envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 64:2819-2824
24. Tuttleman, J. S., J. C. Pugh, and J. W. Summers. 1986. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J. Virol 58:17-25.
25. Ueda, K., T. Tsurimoto, T. Nagatha, O. Chisaka, and K. Matsubara. 1989. An in vitro system for screening anti-hepatitis B virus drugs. Virology 169: 213-216.
26. Van Draanen, N., M. Tisdale, N. Parry, R. Jansen, R. Dornsife, J. Tuttle, D. Averett, and G. Koszalka. 1994. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides. Antimicrob. Agents Chemother. 38:868-871.
27. Wang, G., F. Zoulim, E. Leber, J. Kitson, and C. Seeger. 1994. The role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses. J Virol. 68:8437-8442.
28. Wang, G. H., and C. Seeger. 1992. The reverse transcriptase of hepatitis B virus acts a protein primer for viral DNA synthesis Cell 71:633-670
29. Zoulim, F., and C. Seeger. 1994. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J. Virol. 68:6-13.
30. Zoulim, F., and C. Trépo. 1994. Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications. J Hepatol. 21:142-144.
31. Zoulim, F., G. Wang, and C. Seeger. 1994. Methods for the purification of enzymatically active reverse transcriptase of duck hepatitis B virus, p. 97-100. In K Nishioka, H. Suzuki, S. Mishito, and T. Oda (ed.). Viral hepatitis and liver disease. Proceedings of the International Symposium on Viral Hepatitis and Liver Disease. Springer-Verlag, Tokyo.
32. Zoulim, F., et al. Unpublished data.